Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31611656 | 1.00 | AKR1B1 (0.37) | AKR1B1MPI | |
| SCHEMBL1547638 | 1.00 | AKR1B1 (0.37) | AKR1B1MPI | |
| SCHEMBL23072256 | 1.00 | AKR1B1 (0.37) | AKR1B1MPI | |
| SCHEMBL12396667 | 0.92 | AKR1B1 (0.37) | AKR1B1MPI | |
| SCHEMBL21598343 | 0.87 | AKR1B1 (0.30) | AKR1B1MPI | |
| SCHEMBL9147251 | 0.87 | AKR1B1 (0.30) | AKR1B1MPI | |
| SCHEMBL15329241 | 0.87 | AKR1B1 (0.30) | AKR1B1MPI | |
| L-Fucose SCHEMBL2597764 | 0.84 | — | — | |
| L-Fucose SCHEMBL466429 | 0.84 | — | — | |
| SCHEMBL21330364 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260041089-A1 | PLANT BIOSTIMULANT AND METHODS OF MAKING AND USING SAME | SOLUGEN, INC. (US) | 2026-02-12 | — | — | US | claimed |
| EP-4634396-A1 | BIOBASED SYNTHESIS OF GLUCODIAMINE | Solugen, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| WO-2025151567-A1 | IMPROVED CORROSION INHIBITOR COMPOSITIONS | SOLUGEN, INC. (US) | 2025-07-17 | — | — | WO | claimed |
| US-20250178995-A1 | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF GLUCARIC ACID | SOLUGEN, INC. (US) | 2025-06-05 | — | — | US | claimed |
| WO-2025097180-A1 | BIOBASED COMPOUNDS FOR POLYMER PRODUCTION | SOLUGEN, INC. (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2025090691-A1 | SUGAR OXIDATION CATALYST WITH IMPROVED SELECTIVITY | SOLUGEN, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025076549-A1 | SMALL MOLECULE ACTIVATORS | SOLUGEN, INC. (US) | 2025-04-10 | — | — | WO | claimed |
| WO-2025042851-A1 | BIO-BASED DETERGENT BUILDER | SOLUGEN, INC. (US) | 2025-02-27 | — | — | WO | claimed |
| WO-2025043260-A1 | PROCESS FOR CORROSION CONTROL IN WATER SYSTEMS WITH MINIMIZED ENVIRONMENTAL IMPACT | SOLUGEN, INC. (US) | 2025-02-27 | — | — | WO | claimed |
| US-20250041646-A1 | METHODS AND COMPOSITIONS FOR USE IN FIRE CONTROL | SOLUGEN, INC. (US) | 2025-02-06 | — | — | US | claimed |
| EP-4359586-A1 | NONFERROUS METAL CORROSION INHIBITORS AND METHODS OF USING SAME | Solugen, Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| WO-2024036107-A1 | PLANT BIOSTIMULANT AND METHODS OF MAKING AND USING SAME | SOLUGEN, INC. (US) | 2024-02-15 | — | — | WO | claimed |
| WO-2024036233-A2 | BLOWING AGENTS FOR FOAMED POLYMER APPLICATIONS | SOLUGEN, INC. (US) | 2024-02-15 | — | — | WO | claimed |
| WO-2023164495-A2 | COMPOSITIONS AND METHODS FOR PRODUCTION OF ANTIMICROBIAL AGENTS FROM BIO-RENEWABLE FEEDSTOCKS | SOLUGEN, INC. (US) | 2023-08-31 | — | — | WO | claimed |
| WO-2023081723-A1 | METHODS AND COMPOSITIONS FOR USE IN FIRE CONTROL | SOLUGEN, INC. (US) | 2023-05-11 | — | — | WO | claimed |
| US-20230121990-A1 | COMPOSITIONS AND METHODS FOR PRODUCTION OF GLUCOSE OXIDATION PRODUCTS | SOLUGEN, INC. (US) | 2023-04-20 | — | — | US | claimed |
| US-20230096662-A1 | COMPOSITIONS AND METHODS FOR 2,5-FURAN DICARBOXYLIC ACID PRODUCTION | SOLUGEN, INC. (US) | 2023-03-30 | — | — | US | claimed |
| EP-4118221-A1 | COMPOSITIONS AND METHODS FOR 2,5-FURAN DICARBOXYLIC ACID PRODUCTION | Solugen, Inc. (US) | 2023-01-18 | — | — | EP | claimed |
| EP-4114930-A1 | COMPOSITIONS AND METHODS FOR PRODUCTION OF GLUCOSE OXIDATION PRODUCTS | Solugen, Inc. (US) | 2023-01-11 | — | — | EP | claimed |
| WO-2022272299-A1 | NONFERROUS METAL CORROSION INHIBITORS AND METHODS OF USING SAME | SOLUGEN, INC. (US) | 2022-12-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250178995-A1 | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF GLUCARIC ACID | G6PD, SOD1, UGDH | AKR1B1 484/4885MPI 313/4885 |
| US-20260041089-A1 | PLANT BIOSTIMULANT AND METHODS OF MAKING AND USING SAME | GMDS, ALG1, PGD | AKR1B1 257/4885MPI 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.